nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acknowledging gray areas: 2015 vs. 2009 American Thyroid Association differentiated thyroid cancer guidelines on ablating putatively low-intermediate-risk patients
|
Frangos, Savvas |
|
2016 |
44 |
2 |
p. 185-189 |
artikel |
2 |
Adjuvant post-operative I-131 therapy in differentiated thyroid carcinoma: are the 2015 ATA guidelines an exact science or a dark art?
|
Verburg, Frederik A. |
|
2016 |
44 |
2 |
p. 183-184 |
artikel |
3 |
Brain perfusion SPECT for brain death assessment
|
Coelho, Pedro Barata Silva |
|
2016 |
44 |
2 |
p. 350-351 |
artikel |
4 |
Characterization of [11C]Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brain
|
Yang, Kai-Chun |
|
2016 |
44 |
2 |
p. 308-320 |
artikel |
5 |
Clinical values of left ventricular mechanical dyssynchrony assessment by gated myocardial perfusion SPECT in patients with acute myocardial infarction and multivessel disease
|
Cho, Sang-Geon |
|
2016 |
44 |
2 |
p. 259-266 |
artikel |
6 |
Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for 89Zr-immuno-PET
|
Vugts, Danielle J. |
|
2016 |
44 |
2 |
p. 286-295 |
artikel |
7 |
Critical considerations on the predictive value of end-of-treatment FDG-PET in lymphoma
|
Adams, Hugo J. A. |
|
2016 |
44 |
2 |
p. 342-343 |
artikel |
8 |
Distinguishing synchronous from metachronous manifestation of distant metastases: a prognostic feature in differentiated thyroid carcinoma
|
Sabet, Amir |
|
2016 |
44 |
2 |
p. 190-195 |
artikel |
9 |
Do we need FDG-PET/CT to assess atherosclerosis?
|
Pipitone, Nicolò |
|
2016 |
44 |
2 |
p. 247-248 |
artikel |
10 |
Editorial European Journal of Nuclear Medicine and Molecular Imaging
|
Beer, Ambros J. |
|
2016 |
44 |
2 |
p. 284-285 |
artikel |
11 |
Erratum to: Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATE
|
Sansovini, Maddalena |
|
2016 |
44 |
2 |
p. 352 |
artikel |
12 |
18F-FBPA as a tumor-specific probe of L-type amino acid transporter 1 (LAT1): a comparison study with 18F-FDG and 11C-Methionine PET
|
Watabe, Tadashi |
|
2016 |
44 |
2 |
p. 321-331 |
artikel |
13 |
68Ga-PSMA PET/CT with MRI fusion: spinal cord metastasis from prostate cancer
|
Langsteger, Werner |
|
2016 |
44 |
2 |
p. 348-349 |
artikel |
14 |
123I-mIBG scintigraphy in neuroblastoma: development of a SIOPEN semi-quantitative reporting ,method by an international panel
|
Lewington, V. |
|
2016 |
44 |
2 |
p. 234-241 |
artikel |
15 |
Lymphocyte function following radium-223 therapy in patients with metastasized, castration-resistant prostate cancer
|
Barsegian, Vahé |
|
2016 |
44 |
2 |
p. 242-246 |
artikel |
16 |
Nuclear medicine imaging of multiple myeloma, particularly in the relapsed setting
|
Waal, Esther G. M. de |
|
2016 |
44 |
2 |
p. 332-341 |
artikel |
17 |
Preclinical in vivo and in vitro comparison of the translocator protein PET ligands [18F]PBR102 and [18F]PBR111
|
Eberl, S. |
|
2016 |
44 |
2 |
p. 296-307 |
artikel |
18 |
Predictive medicine: towards a multi-parametric imaging for a personal risk stratification
|
Guedj, Eric |
|
2016 |
44 |
2 |
p. 196-198 |
artikel |
19 |
Radioiodine – the success story of Nuclear Medicine
|
McCready, V. Ralph |
|
2016 |
44 |
2 |
p. 179-182 |
artikel |
20 |
Recurrent bladder carcinoma: clinical and prognostic role of 18 F-FDG PET/CT
|
Alongi, Pierpaolo |
|
2016 |
44 |
2 |
p. 224-233 |
artikel |
21 |
Reply to letter of Adams and Kwee: Critical considerations on the predictive value of end-of-treatment FDG/PET in lymphoma
|
Fallanca, Federico |
|
2016 |
44 |
2 |
p. 344-345 |
artikel |
22 |
Texture analysis of 18F-FDG PET/CT to predict tumour response and prognosis of patients with esophageal cancer treated by chemoradiotherapy
|
Nakajo, Masatoyo |
|
2016 |
44 |
2 |
p. 206-214 |
artikel |
23 |
The delicate balance between present and future
|
Spadafora, Marco |
|
2016 |
44 |
2 |
p. 346-347 |
artikel |
24 |
The natural history of takotsubo syndrome: a two-year follow-up study with myocardial sympathetic and perfusion G-SPECT imaging
|
Sestini, Stelvio |
|
2016 |
44 |
2 |
p. 267-283 |
artikel |
25 |
The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas
|
Palmerini, Emanuela |
|
2016 |
44 |
2 |
p. 215-223 |
artikel |
26 |
Thoracic aorta calcification but not inflammation is associated with increased cardiovascular disease risk: results of the CAMONA study
|
Blomberg, Björn A. |
|
2016 |
44 |
2 |
p. 249-258 |
artikel |
27 |
Volume-based predictive biomarkers of sequential FDG-PET/CT for sunitinib in cancer of unknown primary: identification of the best benefited patients
|
Ma, Yifei |
|
2016 |
44 |
2 |
p. 199-205 |
artikel |